ABPI Logo
  • Developing medicines
    • Responding to COVID-19
    • Clinical trials and research
    • Building a thriving environment for medicine discovery
    • UK-EU Future Relationship
    • Life Sciences Industrial Strategy
    • ABPI Medical Representatives Exam
  • Accessing medicines
    • How medicines are priced in the UK
    • Working with the NHS
    • Supply chain
    • Antimicrobial resistance (AMR)
    • Vaccines
    • What is the NICE Methods Review?
    • Rare diseases: Facing three challenges
  • Our ethics
    • ABPI Code of Practice
    • Disclosure UK
    • Appropriate prescribing
    • Patient & public involvement
  • Member representation
    • Events
    • Full membership
    • Working with our members​
    • ABPI Members List
    • Membership benefits
  • Who We Are
  • Media
  • Publications
  • Facts and Figures
  • Contact Us
MY ABPI LOGIN
 
  • The Association of the British Pharmaceutical Industry
  • Facts and figures
  • Global pharmaceutical market
  • Shares of the global pharmaceutical markets

Shares of the global pharmaceutical markets

The US market continues to represent the single greatest share of the global pharmaceutical market (44.5% in 2016) and is over four times larger than the next largest market, China, which saw a recent decline in the value of its market (7.9% in 2016). Year-on-year variations must be considered before concluding trends.

The EU “Big 5” markets continue to decline as a relative share of the global market for pharmaceuticals, and the recent decline in the UK to a share value of 2.4% in 2016 reflects not only a relative decline as a share of the global market but also nominal decline in expenditure back to 2011 current values.

IMS Health estimates sales through all distribution channels in all countries, whether these channels are audited by IMS Health or not.  These estimates are intended to include both prescription and most non-prescription products.  These data are provided in millions of US dollars, current values, at list prices.

Global pharmaceutical market

  • Global health expenditure as a share of GDP
  • Global pharmaceutical expenditure as a share of health expenditure
  • Top 10 pharmaceutical markets by value (USD)
  • Shares of the global pharmaceutical markets
  • Top 10 pharmaceutical markets by value (USD) 2011-2017
  • Market shares for medicines launched in the previous 5 years

ABPI

The Association of the British Pharmaceutical Industry is a company limited by guarantee registered in England and Wales 
(registered number 09826787) and its registered office is at 7th Floor Southside,105 Victoria Street, London, SW1E 6QT.
Telephone +44 (0) 207 9303477

© ABPI 2021
  • Twitter Logo
  • LinkedIn
  • YouTube Logo

Devolved Nations

  • Cymru Wales
  • Northern Ireland
  • Scotland

Quick Links

  • ABPI Exam
  • Disclosure UK
  • Frequently Asked Questions
  • Careers
  • Schools
  • Acronym buster

Website Info

  • Terms and conditions
  • Accessibility
  • Cookie Policy

Prescription Medicines Code of Practice Authority (PMCPA)

The Prescription Medicines Code of Practice Authority (PMCPA) was established by The Association of the British Pharmaceutical Industry to operate the ABPI Code of Practice for the Pharmaceutical Industry independently of the ABPI. The PMCPA is a division of ABPI which is a company registered in England and Wales (registered number 09826787) with its registered office at 7th Floor, Southside, 105 Victoria Street, London SW1E 6QT.

Office of Health Economics (OHE)

The Office of Health Economics (OHE) is a company limited by guarantee registered in England and Wales (registered number 09848965) and its registered office is at 7th Floor Southside, 105 Victoria Street, London, SW1E 6QT. OHE provides independent research, advisory and consultancy services on policy implications and economic issues within the pharmaceutical, health care and biotechnology sectors.